Decision

UK REACH authorisation for Lonza Biologics Plc: 30 June 2023

Decision on application for authorisation under UK REACH.

• From: Department for Environment, Food & Rural Affairs
• Published: 11 July 2023

Documents

UK REACH authorisation for Lonza Biologics Plc 30 June 2023

PDF, 159 KB, 10 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO).

Authorised use

Use of 4-tert-OPnEO for virus inactivation via solvent/detergent treatment in the manufacture of recombinant medicinal active pharmaceutical ingredients from mammalian cell cultures.

Holder of the authorisation and authorisation number

Lonza Biologics Plc, (UKREACH/23/01/0).

Date of decision

30 June 2023

Published 11 July 2023